It's All About-Jdrf-Boise City-Researching Type 1 Diabetes
JDRF is the leading global organization funding T1D research with more than 100 U.S. locations and 6 international affiliates. Since inception, JDRF has contributed over $1.9B to T1D research and including $98M in 2014. JDRF is currently funding 45 human clinical trials of potential T1D therapies. Approximately 80% of JDRF expenditures directly support T1D research and research-related education.
JDRF’s mission is to find a cure for type 1 diabetes (T1D) and its complications through the support of research.
JDRF International is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, policy influence, and a working plan to better treat, prevent, and eventually cure T1D.As the largest charitable supporter of T1D research, JDRF is currently sponsoring more than $568 million in scientific research in 17 countries. Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. The full set of credits is listed here http://broadcaster.beazil.net/public/credits/youtube/videos/41985 In type 1 diabetes, the pancreas, a large gland behind the stomach, stops making insulin because the cells that make the insulin have been destroyed by the body’s immune system. Without insulin, the body’s cells cannot turn glucose (sugar), into energy. People with type 1 diabetes depend on insulin every day of their lives to replace the insulin the body cannot produce. They must test their blood glucose levels several times throughout the day. The onset of type 1 diabetes typically occurs in people under 30 years, but can occur at any age. About 10-15% of all cases of diabetes are type 1. Without insulin the body burns its own fats as a substitute which releases chemical substances in the blood. Without ongoing injections of insulin, the dangerous chemical substances will accumulate and can be life threatening if it is not treated. Boise is the capital and most populous city of the U.S. state of Idaho, as well as the county seat of Ada County. Located on the Boise River, it anchors the Boise City-Nampa metropolitan area and is the largest city between Salt Lake City, Utah and Portland, Oregon. As of the 2010 Census, the population of Boise was 205,671. It is also the 99th largest U.S. city by population. The 2012 U.S. Census Population Estimates that 212,303 people reside within the city. The Boise metropolitan area is home to about 616,500 people and is the most populous metropolitan area in Idaho, containing the state’s three largest cities; Boise, Nampa, and Meridian. Boise City is the third most populous metropolitan area in the United States’ Pacific Northwest region (behind only those of Seattle and Portland). JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
It seems important remind about the main points of that topic –
JDRFCC,Food insecurity (FI),certified diabetes educator,Blood Glucose Level,Global Diabetes Research,treatment therapies,Glucose Control,Autoantigen Specific Immune Therapies,leading global organization,Mary Tyler Moore,insulin-independent glucose,Medical Research Council,ABCs of diabetes,Promise Gala,CGM,Afrezza,EDIC Study,treatment of diabetes,Long Acting Insulin,Greater Louisville Walk,metformin,T1D management,Juvenile Diabetes,T1D Community,PIs,insulin-dependent diabetes mellitus,At Risk,Diabetes Research,diabetogenic,precise,Humalog,premixed insulin,fundraise,at-risk relatives,heart attack,insulin resistance,rosiglitazone,DPP-4 inhibitors,Research funding,thiazolidinedione,biguanide,longer-acting.